A Managing Director with Manatt Health, Christina Farr brings vast knowledge of the emerging digital and health technology landscape. Chrissy has impressive communications savvy and a deep understanding of the health industry and emerging trends, with an emphasis on the intersection of health and venture capital. She provides a range of go-to-market, fundraising / investor relations, and M&A counsel to both emerging and established companies as well as the investors behind them. Christina will also be a senior advisor to Manatt's venture fund.

Alongside two brilliant friends, I co-founded the Clinicians who VC community and early stage fund Scrub Capital. We are a multidisciplinary, collaborative group of 600 clinician investors, founders, and operators working together to build and fund early stage healthcare companies. Note we are a fund, not an angel syndicate but welcome angel coinvestors. Scrub Capital is not yet very public, but we are writing checks. You can learn more and submit investment opportunities here: https://forms.gle/o7zJStwj8ZPAQVoY8

I write a weekly newsletter about the health-tech industry that's read by more than 20,000 people. If you'd like to discuss opportunities to collaborate, reach me at @christina@secondopinion.media. Second Opinion houses my speaking activities, writing, podcast and other editorial projects.

Leveraging content and community to invest in health-technology from seed through Series C. Investor and board observer in Caraway and Oath Care. Board observer for WithMe Health and PeerWell (sold to Bardavon in ‘22). Built a Substack newsletter with thousands of subscribers and more than 50,000 readers called Second Opinion. Founded a Slack group for clinicians who want to learn about venture called Clinicians Who VC. Speaker at dozens of industry conferences and co-chair for Fortune Brainstorm Health in 2023.

Specialize in features, analysis, investigations and breaking news of how Silicon Valley's biggest technology companies are moving into health care. Stepped up to cover Covid-19 in the early days of the pandemic and helped spearhead several popular series. Host of a "guinea pig" series for CNBC digital video, where I experimented with wearable devices, tracked various aspects of my health for weeks, and experimented with fad diets. Occasional contributor to CNBC's Squawk Alley, CNBC's Closing Bell, Fast Money and TODAY show.

Assisted in editorial strategy and direction for Classical Voice.

Covering health and technology for Fast Company's online site and magazine. Specializing in electronic medical records, health software, genetics and biotechnology. Broke news on Apple's acquisition of its first medical startup, Gliimpse. Covered Fitbit's ambitions in the enterprise; Apple's foray into hospitals; Illumina's ambitions in consumer genomics.

As Reuters' Apple reporter, responsible for breaking news on the beat and the broader ecosystem. Broke news on: Apple's talks with Federal Trade Commission, Apple's enterprise assault and partnerships, Google X's Life Sciences business unit, the first hospitals to adopt Apple's HealthKit service, as well as Facebook's plans to develop applications for patients.Featured tech expert on television segments on NBC, ABC and Reuters TV. Panelist at RockHealth's Innovation Summit, among other health conferences.Winner: Women 2.0's "One to Watch in Media" Award in 2015.

Lead reporter on VentureBeat's first investigative editorial team.Broke national news on the regulatory crackdown against California's bootcamps (pickup from Associated Press) and 23andMe's privacy holes. Published an early prototype of the Samsung Galaxy Gear smartwatch a week before launch (pickup from Wall Street Journal, USA Today and others.)Featured expert on KRON4, ABC, NBC and NPR. Regular contributor of long-form interviews to the Telegraph's Wonder Women section. Named one of "8 women doing big things in tech right now" by Refinery29 and Business Insider.